Viatris Inc. (VTRS): Price and Financial Metrics

Viatris Inc. (VTRS): $9.75

0.14 (+1.46%)

POWR Rating

Component Grades








Add VTRS to Watchlist
Sign Up

VTRS Price/Volume Stats

Current price $9.75 52-week high $12.40
Prev. close $9.61 52-week low $8.74
Day low $9.62 Volume 1,984,266
Day high $9.79 Avg. volume 9,086,635
50-day MA $9.34 Dividend yield 5.12%
200-day MA $9.86 Market Cap 11.70B

VTRS Stock Price Chart Interactive Chart >


  • Value is the dimension where VTRS ranks best; there it ranks ahead of 99.42% of US stocks.
  • VTRS's strongest trending metric is Growth; it's been moving up over the last 177 days.
  • VTRS ranks lowest in Momentum; there it ranks in the 8th percentile.

VTRS Stock Summary

  • VTRS's went public 35.99 years ago, making it older than 90.94% of listed US stocks we're tracking.
  • With a price/earnings ratio of 6.14, VIATRIS INC P/E ratio is greater than that of about only 8.63% of stocks in our set with positive earnings.
  • VIATRIS INC's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 24.68%, greater than the shareholder yield of 92.55% of stocks in our set.
  • Stocks that are quantitatively similar to VTRS, based on their financial statements, market capitalization, and price volatility, are CW, BAX, IART, PLPC, and OC.
  • VTRS's SEC filings can be seen here. And to visit VIATRIS INC's official web site, go to

VTRS Valuation Summary

  • VTRS's price/earnings ratio is 6.2; this is 76.65% lower than that of the median Healthcare stock.
  • VTRS's price/sales ratio has moved down 4.3 over the prior 243 months.

Below are key valuation metrics over time for VTRS.

Stock Date P/S P/B P/E EV/EBIT
VTRS 2023-11-20 0.7 0.5 6.2 9.2
VTRS 2023-11-17 0.7 0.5 6.2 9.1
VTRS 2023-11-16 0.7 0.5 6.0 9.0
VTRS 2023-11-15 0.7 0.5 6.1 9.1
VTRS 2023-11-14 0.7 0.5 6.0 9.1
VTRS 2023-11-13 0.7 0.5 5.9 9.0

VTRS Growth Metrics

    Its 5 year net cashflow from operations growth rate is now at -11.78%.
  • The 4 year cash and equivalents growth rate now stands at -20.92%.
  • Its 4 year price growth rate is now at -55.64%.
VTRS's revenue has moved up $1,124,600,000 over the prior 15 months.

The table below shows VTRS's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2022-09-30 16,728.3 3,333.1 803.6
2022-06-30 17,186.7 3,549.7 760.8
2022-03-31 17,647.7 3,306.6 167.7
2021-12-31 17,886.3 3,016.9 -1,269.1
2021-09-30 17,168.2 2,530 -1,921.1
2021-06-30 15,603.7 1,969.4 -2,046.9

VTRS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • VTRS has a Quality Grade of D, ranking ahead of 8.02% of graded US stocks.
  • VTRS's asset turnover comes in at 0.298 -- ranking 155th of 682 Pharmaceutical Products stocks.
  • CRIS, KDNY, and AGIO are the stocks whose asset turnover ratios are most correlated with VTRS.

The table below shows VTRS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.298 0.277 -0.030
2021-03-31 0.302 0.292 -0.027
2020-12-31 0.312 0.318 -0.011
2020-09-30 0.375 0.363 0.058
2020-06-30 0.375 0.356 0.052
2020-03-31 0.374 0.344 0.047

VTRS Price Target

For more insight on analysts targets of VTRS, see our VTRS price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $20.21 Average Broker Recommendation 1.72 (Moderate Buy)

Viatris Inc. (VTRS) Company Bio

Viatris Inc. is an American global healthcare company headquartered in Canonsburg, Pennsylvania. The company was formed through the merger of Mylan and Upjohn, a division of Pfizer, on November 16, 2020. (Source:Wikipedia)

VTRS Latest News Stream

Event/Time News Detail
Loading, please wait...

VTRS Latest Social Stream

Loading social stream, please wait...

View Full VTRS Social Stream

Latest VTRS News From Around the Web

Below are the latest news stories about VIATRIS INC that investors may wish to consider to help them evaluate VTRS as an investment opportunity.

Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024

Often the best investments are out-of-favor and trade at silly cheap valuations.

Omor Ibne Ehsan on InvestorPlace | November 30, 2023

Insider Sell Alert: President, Greater China Xiangyang Ni Sells 14,937 Shares of Viatris Inc (VTRS)

In the realm of stock market movements, insider trading activity is often a significant indicator that investors keep a close eye on.

Yahoo | November 25, 2023

Viatris Partners With Comfort Cases to Support Youth in U.S. Foster Care

Community Activity Part of Company's Impact Week Anniversary CelebrationPITTSBURGH, PA / ACCESSWIRE / November 21, 2023 / Viatris (NASDAQ:VTRS), a global healthcare company, today announced that it has packed 1,000 backpacks in partnership with Comfort ...

Yahoo | November 21, 2023

Viatris Inc's Dividend Analysis

Viatris Inc (NASDAQ:VTRS) recently announced a dividend of $0.12 per share, payable on 2023-12-15, with the ex-dividend date set for 2023-11-22. As investors look forward to this upcoming payment, the spotlight also shines on the company's dividend history, yield, and growth rates. Using the data from GuruFocus, let's look into Viatris Inc's dividend performance and assess its sustainability.

Yahoo | November 21, 2023

7 Low P/E Stocks Poised to Rebound

Each of these seven low P/E value stocks trades for under 10 times earnings, but could rise to a much higher valuation as sentiment improves.

Thomas Niel on InvestorPlace | November 20, 2023

Read More 'VTRS' Stories Here

VTRS Price Returns

1-mo 7.23%
3-mo -1.24%
6-mo 6.44%
1-year -6.44%
3-year -38.05%
5-year N/A
YTD -8.12%
2022 -14.29%
2021 -26.12%
2020 N/A
2019 N/A
2018 N/A

VTRS Dividends

Ex-Dividend Date Type Payout Amount Change
Loading, please wait...
View Full VTRS Dividend History

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!